We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Clues into How Cells Achieve Immortality

By LabMedica International staff writers
Posted on 28 Apr 2010
Print article
Swedish investigators can now show that cells that grow forever, becoming immortal, obtain this capacity through gradual changes in the expression of genes that control the repair of DNA damage and regulate growth and cell death. Their research also shows that activation of the enzyme complex telomerase, which is essential for unlimited growth, occurs late in this process.

The study's findings, published in the April 2010 issue of the journal Aging Cell, was performed by a research team from Umeå University (Sweden) and directed by Prof. Göran Roos at the department of medical bioscience, pathology. The study's findings provide more insights into how cells' telomeres are regulated during the process that leads to perpetuating the life of cells.

One type of blood cells, lymphocytes, were analyzed on repeated occasions during their cultivation in an incubator until they achieved the ability to grow an unlimited number of cell divisions, a process that is termed immortalization. In experiments, immortalization can be achieved following genetic manipulation of cells in various ways, but in the lymphocytes under study, this occurred spontaneously. This is an atypical phenomenon that can be compared to the development of leukemia in humans, for example.

The ends of chromosomes, the telomeres, are important for the genetic stability of organisms' cells. In normal cells, telomeres are shortened with every cell division, and at a specific short telomere length, they stop dividing. With the occurrence of genetic mutations, the cells can continue to grow even though their telomeres continue to be shortened. At a critically short telomere length, however, a so-called crisis occurs, with imbalance in the genes and massive cell death. In rare cases, the cells survive this crisis and become immortalized. In earlier research, this transition from crisis to eternal life has been associated with the activation of telomerase, an enzyme complex that can lengthen cells' telomeres and help stabilize the genes. A typical finding is that cancer cells have active telomerase.

The current study demonstrated that cells initially lose telomere length with each cell division, as expected, and after a while enter a crisis stage with massive cell death. Those cells that survive the crisis and become immortalized evince no activation of telomerase; instead, this happens later in the process. The Umeå researchers discovered that the expression of genes inhibiting telomerase is reduced in cells that get through the crisis, but telomerase was not activated until positively regulating factors were activated, thus allowing the telomeres to become stabilized through lengthening. By analyzing the genetic expressions, the scientists were able to show that the cells that survived the crisis stage had mutations in genes that are crucial to the repair of DNA damage and the regulation of growth and cell death. This discovery provides new insights into the series of events that needs to occur for cells to become immortalized, and it will have an impact on future studies of leukemia, for example.

The studies were performed in collaboration with the Center for Oncology and Applied Pharmacology, University of Glasgow (UK) and the Maria Skodowska-Curie Memorial Cancer Center and Institute of Oncology (Warsaw, Poland).

Related Links:
Umeå University

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
UHF RFID Tag and Inlay
AD-321r6/AD-321r6-P
New
LH ELISA
Luteinizing Hormone ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.